宫颈癌患者腔内同步放化疗与局部感染危险因素及疗效的研究
[Abstract]:Objective to investigate the clinical effect of concurrent radiotherapy and chemotherapy in the treatment of advanced cervical cancer and to analyze the risk factors of cervical cancer complicated with local infection. Methods from January 2010 to January 2011, 60 patients with advanced cervical cancer were randomly divided into two groups: the observation group (n = 30) and the control group (n = 30). The control group was treated with radiotherapy alone, and the observation group was treated with concurrent radiotherapy and chemotherapy. The short term curative effect and adverse reaction were compared between the two groups, followed up for 5 years, the near and long term curative effect were compared, and the influencing factors of infection were analyzed. Results the short-term total effective rate of the observation group was 93.33% significantly higher than that of the control group 73.33% (P0.05), the 5-year survival rate of the observation group was 76.67% significantly higher than that of the control group 53.33% (P0.05), the local recurrence rate and distant metastasis rate of the observation group were 13.33% significantly lower than that of the control group (26.67%), and the control group was significantly lower than the control group (P0.05). The incidence of adverse reaction was 13.33%, and there was no significant difference between observation group and observation group (23.33%). In the observation group, 20 cases of local infection occurred, the infection rate was 66.67%, the hospital stay was 7 days, the patients were complicated with basic diseases, and the medical staff were not skilled in operation. Urinary catheter indwelling time 3 days, no use of antibiotics Figo stage IVb stage of cervical cancer patients with intracavitary radiotherapy associated with local infection of the independent risk factors (P0.05). Conclusion simultaneous radiotherapy and chemotherapy is effective in the treatment of advanced cervical cancer, and the survival rate is improved.
【作者单位】: 郑州大学附属肿瘤医院妇瘤科六病区;
【分类号】:R737.33
【相似文献】
相关期刊论文 前10条
1 曾四元;李隆玉;舒宽勇;潘玫;李汉萍;罗兵;;同步放化疗和单纯放疗治疗ⅡB~ⅢB期宫颈癌的疗效比较[J];癌症;2008年09期
2 阿依姑力·买买提艾力;张泽高;杨杰;;锎252中子同步放化疗治疗中晚期宫颈癌临床分析[J];新疆医学;2014年09期
3 郝敏;张娜;;宫颈癌新辅助化疗与同步放化疗[J];中国实用妇科与产科杂志;2010年03期
4 宋红梅;;59例宫颈癌术前同步放化疗的疗效观察[J];中外妇儿健康;2011年04期
5 刘云琴;程广源;;同步放化疗治疗宫颈癌的探讨[J];安徽医药;2007年01期
6 陈森;刘陶文;;局部中晚期宫颈癌的同步放化疗研究现状[J];内科;2014年04期
7 黄曼妮,吴令英,高菊珍;宫颈癌的同步放化疗[J];癌症进展;2004年05期
8 张云霞;古扎丽努尔·阿不力孜;;同步放化疗治疗中晚期宫颈癌366例临床分析[J];新疆医科大学学报;2006年01期
9 王海红;;同步放化疗治疗中晚期宫颈癌168例临床分析[J];中国医药指南;2008年21期
10 范波;敬巧;;氟尿嘧啶联合顺铂同步放化疗治疗中晚期宫颈癌的临床疗效观察[J];华西医学;2008年02期
相关硕士学位论文 前6条
1 陈琦;Ⅰb-Ⅱa期宫颈鳞癌术后具有中危因素的患者辅助化疗与同步放化疗对预后影响的随机对照研究[D];广西医科大学;2016年
2 覃爱秋;宫颈癌术后同步放化疗对比单纯放疗的疗效和安全性的Meta分析[D];广西医科大学;2017年
3 饶s,
本文编号:2190499
本文链接:https://www.wllwen.com/yixuelunwen/fuchankeerkelunwen/2190499.html